| EPC458 | Impact of the COVID-19-related economic crisis and the mitigation effects of social protection on HIV/AIDS and Tuberculosis: an integrated economic, mathematical and epidemiological study | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPC459 | Impact of the Covid-19 pandemic on HIV testing in a global HIV/AIDS support program | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPC460 | HIV prevention and treatment in the era of COVID-19 in South Africa | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPC461 | Lower CD4 count in new clients enrolled during Covid-19 pandemic in a global HIV program | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPC462 | Determinants of psychological distress and perceived changes in associated HIV/HCV risks during the COVID-19 pandemic among people who use drugs in Montreal, Canada | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPC463 | Effect of COVID-19 on HIV prevention among the LGBTQ+ population in New York City (NYC) | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPC464 | SARS CoV-2 seroprevalence in a cohort of people living with HIV before COVID-19 vaccination, Rio de Janeiro, Brazil | E-poster | COVID-19 testing |
| EPC465 | Lopinavir/Ritonavir post-exposure prophylaxis did not protect against Covid-19 | E-poster | COVID-19 prevention |
| EPC466 | Coronavirus vaccine safety in people living with HIV/AIDS | E-poster | COVID-19 prevention |
| EPC467 | Omicron: infection rate and clinical outcomes in Johannesburg, South Africa | E-poster | COVID-19 prevention |